This is consistent with previous work showing that elevated TSLP in lungs correlates with increased AHR in both mouse models and human asthma, and that neutralizing TSLP or downstream cytokines like IL-4 and IL-13 mitigates AHR and airway inflammation [42,43]. Here, IL13 is linked to asthma.